Eurofins has completed the acquisition of bioskin GmbH, a company specialising in trials for drugs, medical devices, food supplements and cosmetics. With this new operation, Eurofins carries on its strategy to diversify its clinical testing footprint in dermatology.
Over the last 30 years bioskin has built a reputation for excellence in providing clinical trials in dermatology. bioskin employs over 60 staff in its facility in Hamburg and has generated revenues of over EUR 11 million in...

- Industry buzz /

© 2005 - 2019 Ladocare. All rights reserved.

beautydailynews does not provide medical advice, diagnosis or treatment.

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

Forgot your details?